Overview

A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections

Status:
Terminated

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and tolerability of doripenem compared to cefepime in children hospitalized with complicated urinary tract infections.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen Research & Development, LLC

Treatments:

Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Cefepime
Cephalosporins
Clavulanic Acid
Clavulanic Acids
Doripenem